Gonadorelin
Reviewed
Short answer
Gonadorelin is a 10-amino-acid version of a body signal. The signal is called gonadotropin-releasing hormone (GnRH). It tells the pituitary gland to release two reproductive hormones. FDA approved human products called Factrel and Lutrepulse. Current human drug records list both as discontinued. Current animal products are not approved for people. Some studies used a pump to copy the body's normal signal pattern in people with specific hormone disorders. Those results do not show a general testosterone or fertility benefit.
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Read the study findingsAlso known as Gonadorelin decapeptide · Factrel · Lutrepulse
Legal status Is Gonadorelin legal? See the status table
Study and product details
What it is
Gonadorelin is a lab-made version of a body signal. The signal is called gonadotropin-releasing hormone (GnRH). It tells the pituitary gland, a small gland below the brain, to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH help control ovulation, testosterone production, and sperm development. Gonadorelin is not the same as a long-acting GnRH drug.
Type of peptide: Synthetic gonadotropin-releasing hormone. This describes what the substance is or how it works. It does not show that it is safe, effective, or approved.
What has been studied?
- Moderate: Useful evidence exists, but important limits remain.
- Limited: Research is too small or incomplete, or does not directly answer this question.
Human studies measured ovulation and sperm development in people with defined hormone disorders. They do not establish broad fertility or testosterone benefits.
Human studies show that gonadorelin can trigger reproductive hormone signals in selected disorders and controlled settings.
Former product records and human studies provide limited safety information. They do not define uncommon harms or the safety of current unapproved products.
FDA records identify the active molecule, former human products, and current animal products. Each finished product needs its own review.
Products with the same ingredient can differ.
The ingredient name does not tell you everything about a product. Check its other ingredients, its form, how it enters the body, and the use and people covered by the research or approval.
None identified. Factrel and Lutrepulse were approved for people in the past. Current human drug records list both as discontinued.
- Historical treatment of hypothalamic amenorrhea
Have a lab test report (COA) for a product sold under this name? Check what the report shows in 10 questions
Not sure if a product sold under this name is a prescription, compounded, or research-only vial? Sort it in 5 questions
What studies found
FDA approved Factrel and Lutrepulse for people. Current records list both as discontinued. Lutrepulse was approved for women with hypothalamic amenorrhea, which can stop periods when the brain sends too little GnRH. Studies used a pump to copy the body's normal signal pattern. One study of 109 women found ovulation in more than 9 in 10. A study of 28 men was not randomized. It found earlier sperm development with the pump, but the overall rate was not clearly different.
These studies did not test gonadorelin during testosterone therapy. They do not show that taking it from time to time protects fertility. They do not show a general testosterone benefit for men without the studied disorders. A compounded or online product is not proven to match former human products or study material. Current FDA-approved animal gonadorelin products are not approved for people.
Which products do these findings apply to?
FDA once approved human products named Factrel and Lutrepulse. Current human drug records list both as discontinued. FDA also lists current cattle products, including a separate Factrel product. Animal approval does not apply to people. A compounded or online product needs its own review.
Fact checks
5 statements checked. Read what the results mean.
“Gonadorelin is the same 10-amino-acid signal as the body's GnRH.”
FDA's identity record lists gonadorelin's 10-amino-acid sequence. The current cattle Factrel label says it has the same sequence as the body's GnRH. This identity fact does not make every product equivalent or approved.
- What this answer is based on
- Official record or product label
- Limits of this answer
- The FDA-identified gonadorelin molecule only. It does not cover every product sold under the name.
Sources for this fact check (2)
“Gonadorelin has never been FDA-approved for people.”
FDA approved Factrel and Lutrepulse for human uses. Current Drugs@FDA records list both products as discontinued. That history does not mean that a current gonadorelin product is approved.
- What this answer is based on
- Official record or product label
- Limits of this answer
- Former U.S. human products and current U.S. human drug records as reviewed August 30, 2026.
Sources for this fact check (3)
“Current animal gonadorelin products are FDA-approved for people.”
FDA lists current gonadorelin products for cattle. Their animal approvals do not approve them for people. One cattle product also uses the Factrel name, but it is not the former human Factrel product.
- What this answer is based on
- Official record or product label
- Limits of this answer
- Current FDA-approved animal products for cattle, not human products.
Sources for this fact check (1)
Show 2 more fact checks
“Any gonadorelin product can preserve fertility during testosterone therapy.”
Human studies used a pump to copy the body's normal signal pattern. They tested people with certain hormone disorders. They did not test gonadorelin during testosterone therapy.
- What this answer is based on
- No reliable studies showing this health result in people
- Limits of this answer
- People using testosterone therapy; the reviewed pump studies did not test this claim.
Sources for this fact check (3)
“Gonadorelin is allowed in tested sport.”
For covered male athletes, the 2026 WADA Prohibited List names gonadorelin under testosterone-stimulating peptides.
- What this answer is based on
- Official record or product label
- Limits of this answer
- Covered male athletes under the 2026 WADA rules; athlete-specific rules can differ.
Sources for this fact check (1)
Risks and safety limits
FDA records and a 2026 warning letter show that each product has its own status. Approval for an animal or a former human product does not approve an online or compounded product for people. This guide gives no dosing, sourcing, injection, fertility, or testosterone-treatment instructions.
For covered male athletes, the 2026 WADA Prohibited List names gonadorelin under testosterone-stimulating peptides. This is not personal clearance. Athletes must check the current rules that apply to them.
Reviewed .Check the rules for athletes ↗Read the official rules ↗Terms used in the studies
- peptide
- a short chain of amino acids
- randomized
- assigned to study groups by chance
- compounded
- made for one patient by a pharmacy, or in batches by a permitted outsourcing facility; a compounded drug is not FDA-approved
- molecule
- one specific chemical substance
- mechanism
- how a substance may cause a body change
- biomarker
- a body or lab measurement, not automatically a health benefit
- outcome
- what the study measured
- amino acid
- a small building block that makes peptides and proteins
Read the sources
Show 13 sources
Review history
Initial brief reviewed FDA identity and approval records, human studies, and current animal-product status. It also checked a 2026 FDA warning letter and the 2026 World Anti-Doping Agency list.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.
Report a factual error